Company intelligence / Profile preview

VaxDesign

Orlando, Florida, United States

Ownership: Private
Employees: ~9
Development stage: Other

Overview

The MIMIC® system is an advanced in vitro model of the human immune system that helps predict immune responses to vaccine and drug candidates. The platform was described as "the most-advanced platform in the field" by Sanofi Pasteur leadership and successfully reproduced their clinical data.

Modalities: In vitro models
Industry: Drug Discovery Services

Partnerships

Sanofi Pasteur (parent company)

Beyond the preview

Go deeper on VaxDesign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VaxDesign.

Explore the full profile